Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wedemeyer

Showing results (61-70 of 1,142) with videos related to

Pageof 115
Sort By:
The Journal of Urology|October 1, 1984
UM-UC-1 and UM-UC-2: characterization of two new human transitional cell carcinoma linesH B Grossman, G Wedemeyer, L Ren
Der Internist|May 1, 2004
[Hepatitis as a travel disease]J Hadem, H Wedemeyer, M P Manns
Gut|August 15, 2006
Treating viral hepatitis C: efficacy, side effects, and complicationsM P Manns, H Wedemeyer, M Cornberg
Organic & Biomolecular Chemistry|June 22, 2007
Model studies for the thiol-mediated methyl transfer to corrinoidsChristina Wedemeyer-Exl, Tamis Darbre, Reinhart Keese
Best Practice & Research. Clinical Gastroenterology|February 4, 2009
Natural history: the importance of viral load, liver damage and HCCKarsten Wursthorn, Michael P Manns, Heiner Wedemeyer
Current Opinion in Investigational Drugs (London, England : 2000)|February 7, 2009
Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infectionIngmar Mederacke, Heiner Wedemeyer, Michael P Manns
Gut|June 8, 2010
Managing HBV in patients with impaired immunityKarsten Wursthorn, Heiner Wedemeyer, Michael P Manns
Expert Opinion on Pharmacotherapy|February 20, 2010
Treatment of HBV/HCV coinfectionAndrej Potthoff, Michael P Manns, Heiner Wedemeyer
Current Gastroenterology Reports|February 5, 2002
Treatment of chronic hepatitis C with PEGylated interferon and ribavirinMarkus Cornberg, Heiner Wedemeyer, Michael P Manns
Gastroenterology|April 28, 2012
Pathogenesis and treatment of hepatitis e virus infectionHeiner Wedemeyer, Sven Pischke, Michael P Manns
Pageof 115

Showing results (61-70 of 1,142) with videos related to

Sort By:
Pageof 115
The Journal of Urology|October 1, 1984
UM-UC-1 and UM-UC-2: characterization of two new human transitional cell carcinoma linesH B Grossman, G Wedemeyer, L Ren
Der Internist|May 1, 2004
[Hepatitis as a travel disease]J Hadem, H Wedemeyer, M P Manns
Gut|August 15, 2006
Treating viral hepatitis C: efficacy, side effects, and complicationsM P Manns, H Wedemeyer, M Cornberg
Organic & Biomolecular Chemistry|June 22, 2007
Model studies for the thiol-mediated methyl transfer to corrinoidsChristina Wedemeyer-Exl, Tamis Darbre, Reinhart Keese
Best Practice & Research. Clinical Gastroenterology|February 4, 2009
Natural history: the importance of viral load, liver damage and HCCKarsten Wursthorn, Michael P Manns, Heiner Wedemeyer
Current Opinion in Investigational Drugs (London, England : 2000)|February 7, 2009
Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infectionIngmar Mederacke, Heiner Wedemeyer, Michael P Manns
Gut|June 8, 2010
Managing HBV in patients with impaired immunityKarsten Wursthorn, Heiner Wedemeyer, Michael P Manns
Expert Opinion on Pharmacotherapy|February 20, 2010
Treatment of HBV/HCV coinfectionAndrej Potthoff, Michael P Manns, Heiner Wedemeyer
Current Gastroenterology Reports|February 5, 2002
Treatment of chronic hepatitis C with PEGylated interferon and ribavirinMarkus Cornberg, Heiner Wedemeyer, Michael P Manns
Gastroenterology|April 28, 2012
Pathogenesis and treatment of hepatitis e virus infectionHeiner Wedemeyer, Sven Pischke, Michael P Manns
Pageof 115